Highly sensitive B cell analysis predicts response to rituximab therapy in rheumatoid arthritis

Abstract

This study is the first to show, using a highly sensitive analysis, that rituximab therapy is associated with variable diminution in B cell numbers. A lack of complete depletion of B cells after 1 infusion was associated with a poorer outcome.